Results 291 to 300 of about 370,832 (346)
Bacteriophages as vaccine platforms: Opportunities and challenges in translation. [PDF]
Hum Vaccin ImmunotherChen W, Peters DL, Lam S, Kettal M.
europepmc +1 more source
StealthX: A Versatile and Potent Exosome-Based Vaccine Platform for the Next Pandemic. [PDF]
Vaccines (Basel)Sun M, Elliott K.
europepmc +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 1514-1522, April 2025.
Takamasa Iwai +4 more
wiley +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Annual Review of Medicine, 1985
Purified from the plasma of hepatitis B carriers, hepatitis B surface antigen particles have been used in a vaccine to prevent hepatitis B. This plasma-derived vaccine is immunogenic, protective, and has an excellent safety record. Indications and strategies for preexposure and postexposure prophylaxis are reviewed.
I M, Jacobson, J L, Dienstag
openaire +3 more sources
Purified from the plasma of hepatitis B carriers, hepatitis B surface antigen particles have been used in a vaccine to prevent hepatitis B. This plasma-derived vaccine is immunogenic, protective, and has an excellent safety record. Indications and strategies for preexposure and postexposure prophylaxis are reviewed.
I M, Jacobson, J L, Dienstag
openaire +3 more sources
Annual Review of Microbiology, 1984
INTRODUCTION...... ..... 221 Vaccines in the Control of Virus Diseases .....
openaire +2 more sources
INTRODUCTION...... ..... 221 Vaccines in the Control of Virus Diseases .....
openaire +2 more sources
Seminars in Oncology, 2005
Recent advances in understanding tumor-specific immunity have introduced new excitement in the clinical development of vaccines for the treatment of cancer. A better understanding of basic immunologic principles has led to a variety of techniques for enhancing tumor-specific immunity through vaccination.
Philip M, Arlen +2 more
openaire +2 more sources
Recent advances in understanding tumor-specific immunity have introduced new excitement in the clinical development of vaccines for the treatment of cancer. A better understanding of basic immunologic principles has led to a variety of techniques for enhancing tumor-specific immunity through vaccination.
Philip M, Arlen +2 more
openaire +2 more sources
VacciTUTOR, 2021
Viral vector vaccines use harmless, non-replicating or replicating viruses to deliver genetic material for production of vaccine antigens into host cell cytoplasm. While viral vector vaccines may theoretically induce life-long immunity with low antigen concentrations, their attenuation, safety and spread to the community are of concern. Vaccines based
Valerie Oriol Mathieu +3 more
openaire +1 more source
Viral vector vaccines use harmless, non-replicating or replicating viruses to deliver genetic material for production of vaccine antigens into host cell cytoplasm. While viral vector vaccines may theoretically induce life-long immunity with low antigen concentrations, their attenuation, safety and spread to the community are of concern. Vaccines based
Valerie Oriol Mathieu +3 more
openaire +1 more source